Lexicon Pharmaceuticals, Inc. (LXRX) stock
LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.72−0.06 (-3.37%)
Close on Nov 18, 2026Market cap $765.32MP/E –Yield –
Lexicon Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Lexicon Pharmaceuticals's market cap was $835.65M on Nov 11, 2026, against $523.07M a year earlier. Over the last 5 years it ranged from $167.28M to $1.02B, with a median of $396.10M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $835.65M | +98.7% |
| 2025 | Dec 31, 2025 | $420.65M | +95.9% |
| 2024 | Dec 31, 2024 | $214.70M | -32.2% |
| 2023 | Dec 29, 2023 | $316.60M | +6.5% |
| 2022 | Dec 30, 2022 | $297.29M | -45.7% |
| 2021 | Dec 31, 2021 | $547.75M | +46.5% |
| 2020 | Dec 31, 2020 | $374.01M | -17.1% |
| 2019 | Dec 31, 2019 | $451.19M | -35.7% |
| 2018 | Dec 31, 2018 | $702.16M | -32.2% |
| 2017 | Dec 29, 2017 | $1.04B | -29.9% |
| 2016 | Dec 30, 2016 | $1.48B | +12.2% |
| 2015 | Dec 31, 2015 | $1.32B | +181.3% |
| 2014 | Dec 31, 2014 | $467.94M | -49.2% |
| 2013 | Dec 31, 2013 | $920.95M | -7.5% |
| 2012 | Dec 31, 2012 | $995.09M | – |
See a number that looks wrong?